MedTrace Logo

Clinical Trial of the Use of Intraperitoneal Local Anaesthetic

NCT00180687 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2015-09-15

Study results available
· View outcomes & findings →

Summary

Patients undergoing keyhole gall bladder removal will be divided into 3 groups, one control, one will have local anaesthetic and the third will have normal saline nebulised into their abdomen before closure of the wounds to reduce postoperative pain. These medications will be given on top of the standard pain management protocol.

Conditions

  • Pain, Postoperative

Interventions

DRUG

Nebulised Bupivacaine intraperitoneally

Nebulised Marcaine (Bupivacaine)

DRUG

Normal Saline

Nebulised Normal Saline

DRUG

Injected Bupivacaine intraperitoneally

Injected Marcaine directly into the peritoneal cavity

OTHER

No Intraperitoneal Therapeutics

No Intraperitoneal Therapeutics given

Sponsors & Collaborators

  • Imperial College London

    lead OTHER

Principal Investigators

  • Nawar A Alkhamesi, MD, PhD · Imperial College London

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2004-10-31
Primary Completion
2005-09-30
Completion
2005-09-30

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00180687 on ClinicalTrials.gov